The Radiation Oncology Devices market is experiencing positive growth as a result of factors such as rising cancer cases, rapid technological development activities, strong R&D initiatives from key players, rising adoption of radiotherapy procedures in cancer treatment, and growing demand for minimally invasive procedures, all of which are contributing to the Radiation Oncology Devices market growth during the forecast period.
DelveInsight’s Radiation Oncology Devices Market Insights report provides the current and forecast market, forthcoming device innovation, individual leading companies’ market shares, challenges, Radiation Oncology Devices market drivers, barriers and trends, and key Radiation Oncology Devices companies in the market.
Radiation Oncology Devices Overivew
Radiation therapy (RT) destroys tumor cells by using high-energy X-rays or other particles. It is used to slow or stop tumor growth and is typically administered after surgery and possibly in conjunction with chemotherapy. External-beam radiation therapy, which delivers radiation from a machine outside the body, is the most common type of radiation treatment. Internal radiation therapy, also known as brachytherapy, is the use of implants to deliver radiation therapy.
Radiation Oncology Devices Market Insights
North America is expected to account for the largest share of the global Radiation Oncology Devices market among all regions. Factors such as rising cancer prevalence, supportive government policies and increased emphasis on promoting oncology research, conducive environment for product development and launches, among others, will drive the growth of the Radiation Oncology Devices market in the region.
Furthermore, the increased emphasis on product development activities and device manufacturers’ keen interest in entering local markets contribute to the growth of regional radiation oncology devices markets. For example, the US Food and Drug Administration (FDA) granted Alpha Tau’s alpha-radiation cancer therapy breakthrough device designation in October 2021 to treat patients with recurrent glioblastoma multiforme (GBM).
These types of product launches in local markets drive radiation oncology devices market product demand. As a result of the interaction of various factors, such as the presence of a large patient population, encouraging reimbursement policies, and new product launches in the region, the North American Radiation Oncology Devices market is expected to grow during the forecast period.
To know more about why North America is leading the market growth in the Radiation Oncology Devices market, get a snapshot of the report Radiation Oncology Devices Market Trends
Recent Developments in the Radiation Oncology Devices Market Report
- In November 2022, Elekta announced the FDA 510(k) clearance of Elekta Esprit, a new Leksell Gamma Knife radiosurgery platform.
- In October 2022, CIVCO Radiotherapy, a global provider of radiotherapy solutions, has announced a partnership with Qfix, a provider of patient positioning and immobilization devices.
- In June 2022, Varian announced today that it had received an IDE from the FDA to advance its Flash clinical research program.
- In February 2022, GT Medical Technologies Inc., creators of GammaTile Therapy announced its 2021 roster of ELITE Distinguished Brain Tumor Specialists that have completed 10 or more GammaTile Therapy procedures in 2021.
- On December 06, 2021, RefleXion Medical Inc. announced that the U.S. Food and Drug Administration (FDA) had granted the company Breakthrough Device Designation for its biology-guided radiotherapy* (BgRT) for use in treating lung tumors. The breakthrough potential of BgRT lies in its ability to detect and then immediately treat moving tumors. It is the first and only technology to use injected radiotracers to produce active signals, called emissions, from each tumor to guide treatment delivery.
- In April 2021, Siemens Healthineers AG announced its completion of the acquisition of Varian Medical Systems, Inc.
To read more about the latest highlights related to Radiation Oncology Devices, get a snapshot of the key highlights entailed in the Radiation Oncology Devices Market Landscape
Key Players in the Radiation Oncology Devices Market
The leading Radiation Oncology Devices companies such as Siemens Healthineers AG, Elekta AB, Accuray Incorporated, IBA Worldwide, C. R. Bard, Inc (BD), Isoray Inc., Mevion Medical Systems, Viewray Technologies, Inc., Eckert & Ziegler BEBIG, ZEISS, GT Medical Technologies, Inc., Hitachi, Ltd., Xoft (iCAD, Inc.), IntraOp Medical, Inc., Panacea Medical Technologies Pvt. Ltd., SIT – S.I.T. Sordina IORT Technologies S.p.A., Sensus Healthcare, Inc., Theragenics, Optivus Proton Therapy, Inc., P-cure, and others are currently dominating the Radiation Oncology Devices market.
COVID-19 Impact Analysis on the Radiation Oncology Devices Market
The Radiation Oncology Devices market is experiencing increased product demand for various reasons, one of which is the rising prevalence of various cancers. Radiation Oncology Devices are in high demand in the field of medical imaging these days. Radiation Oncology Devices is an effective imaging technique that assists physicians in diagnosing cancers in the brain, prostate, lung, and other organs.
However, the high costs of procedures and the side effects associated with radiation may be limiting factors in the growth of the Radiation Oncology Devices market.
Furthermore, the pandemic caused the cancellation of outpatient visits and the suspension of non-emergency hospitals and procedures. As a result, the number of routine clinical examinations of visits and related procedures was reduced.
However, the development of the COVID-19 vaccine has begun the process of economic recovery, with the easing of lockdown restrictions and the return of normalcy in the economic landscape, which has begun the process of resumption of regular healthcare services such as outpatient visits and resumption of healthcare services, thereby increasing demand in the Radiation Oncology Devices market.
Scope of the Intranasal Drug Delivery Market Report
- Coverage: Global
- Study Period: 2019–2027
- Market Segmentation By Type: External Beam Radiation Therapy [Linear Accelerators (Linac), Stereotactic Advanced Electron/Cobalt-60 Linear Accelerators {Gamma Knife, Cyberknife, Tomotherapy}, Proton Therapy, Cyclotron, Synchrotron, Others], Internal Beam Radiotherapy/Brachytherapy
- Market Segmentation By Technology: External Beam Radiation Therapy [Image-Guided Radiotherapy (Igrt), Intensity Modulated Radiotherapy (Imrt), Stereotactic Technology, Proton Beam Therapy, 3D Conformal Radiotherapy (3D CRT), Others], Internal Beam Radiotherapy/Brachytherapy [Low-Dose Rate Brachytherapy, High-Dose Rate Brachytherapy]
- Market Segmentation By Application: External Beam Radiation Therapy (Prostate Cancer, Breast Cancer, Lung Cancer, Head And Neck Cancer, Colorectal Cancer, Others), Internal Beam Radiation Therapy (Prostate Cancer, Gynecological Cancer, Breast Cancer, Cervical Cancer, Penile Cancer, Others)
- Market Segmentation By End-User: Hospitals, Independent Radiotherapy Centers, Others
-
- Market Segmentation By Geography: North America, Europe, Asia-Pacific, and Rest of World
- Key Radiation Oncology Devices Companies: Siemens Healthineers AG, Elekta AB (STO: EKTA-B), Accuray Incorporated (NASDAQ: ARAY), IBA Worldwide (EBR: IBAB), C. R. Bard, Inc (BD), Isoray Inc. (NYSEAMERICAN: ISR), Mevion Medical Systems, Viewray Technologies, Inc., Eckert & Ziegler BEBIG (ETR: EUZ), ZEISS, GT Medical Technologies, Inc., Hitachi, Ltd., Xoft (iCAD, Inc.) (OTCMKTS: SOFT), IntraOp Medical, Inc., Panacea Medical Technologies Pvt. Ltd., SIT – S.I.T. Sordina IORT Technologies S.p.A., Sensus Healthcare, Inc. (NASDAQ: SRTS), Theragenics, Optivus Proton Therapy, Inc., P-cure, and others
- Porter’s Five Forces Analysis, Product Profiles, Case Studies, KOL’s Views, Analyst’s View
- DelveInsight Analysis: The Radiation Oncology Devices market size is expected to grow at a CAGR of 7.78% during the forecast period (2022–2027).
Which MedTech key players in the Radiation Oncology Devices market are set to emerge as the trendsetter explore @Radiation Oncology Devices Companies
Table of Contents
| 1 | Radiation Oncology Devices Market Report Introduction |
| 2 | Radiation Oncology Devices Market Executive summary |
| 3 | Regulatory and Patent Analysis |
| 4 | Radiation Oncology Devices Market Key Factors Analysis |
| 5 | Porter’s Five Forces Analysis |
| 6 | COVID-19 Impact Analysis on Radiation Oncology Devices Market |
| 7 | Radiation Oncology Devices Market Layout |
| 8 | Global Company Share Analysis – Key 3-5 Companies |
| 9 | Company and Product Profiles |
| 10 | Project Approach |
| 11. | About DelveInsight |
Interested in knowing how the Radiation Oncology Devices market will grow by 2027? Click to get a snapshot of the Radiation Oncology Devices Market Analysis
Related Reports
Radiologic Cancer Therapy Market
Radiologic Cancer Therapy Market Insight, Competitive Landscape, and Market Forecast – 2027 report delivers an in-depth understanding of the market trends, market drivers, market barriers, and key Radiologic Cancer Therapy companies, including Accuray, Inc., Nordion Inc., Varian Medical Systems, IsoRay, Inc., Ion Beam Applications SA, among others.
Interventional Radiology Devices Market
Interventional Radiology Devices Market Insight, Competitive Landscape, and Market Forecast – 2027 report delivers an in-depth understanding of market trends, market drivers, market barriers, and key Interventional Radiology Devices companies, including General Electric, Koninklijke Philips N.V., Carestream Health, ESAOTE SPA, Hitachi, Ltd., Hologic, Inc., Shimadzu Corporation, among others.
Cancer Therapy Market Insight, Competitive Landscape, and Market Forecast – 2027 report delivers an in-depth understanding of market trends, market drivers, market barriers, and key Cancer Therapy companies such as GlaxoSmithKline, Eli Lilly & Company, F. Hoffmann-La Roche Ltd, AbbVie Inc., Amgen Inc, among others.
Intratumoral Cancer Therapies Market
Intratumoral Cancer Therapies Market Insight, Epidemiology, and Market Forecast – 2032 report delivers an in-depth understanding of market trends, market drivers, market barriers, and key Intratumoral Cancer Therapies companies such as Daiichi Sankyo, Amgen, Idera Pharmaceuticals, among others.
Liquid Biopsy in Cancer Diagnostics Market
Liquid Biopsy in Cancer Diagnostics Market Insight, Competitive Landscape, and Market Forecast – 2027 report delivers an in-depth understanding of market trends, market drivers, market barriers, and key Liquid Biopsy in Cancer Diagnostics companies such as Myriad Genetics Inc, Exact Sciences Corporation, Biocartis, Sysmex Corporation, among others.
Other Trending Reports
Goitre Market | Thymus Cancer Market | US Healthcare Outlook Report | Venous Stenosis Market | Negative Pressure Wound Therapy Systems Market | Global Kinase Inhibitor in Autoimmune Diseases Market | Metrorrhagia Market | Dysfunctional Uterine Bleeding Market | Hypereosinophilic Syndrome Market | Age-related Vision Dysfunction Market | Dental Lasers Market | CRISPR Therapies Pipeline Insight | Cell And Gene Therapy For Multiple Myeloma Market | Drug Hypersensitivity Market | Dysthymia Market | Persistent Depressive Disorder Market | Cancer Vaccines Market | Global Messenger RNA (mRNA)-based Vaccines and Therapeutics Market |Spirometers Market | Hemodynamic Monitoring Systems Market | Deep Brain Stimulation Devices Market | Genital Herpes Market | Guillain-Barre Syndrome (GBS) Market | Hot Flashes Market | Human Immunodeficiency Virus Type-1 (HIV-1) Market | Hypertrophic Scar Market | Sinus Dilation Devices Market | Artificial Cornea and Corneal Implant Market |Peripheral Neuritis Market | Peripheral Vascular Devices Market | Diphtheria Market | Glioma Market | Fallopian Tube Cancer Market | Implantable Cardioverter Defibrillators (ICDs) Market | Smart Inhalers Market | Thyroid Cancer Market | Hemostasis Market | Peptic Ulcers Market
Related Healthcare Blogs
Upcoming Oncological Drugs in 2022
Metastatic Castration-Sensitive Prostate Cancer Treatment Market
Related Healthcare Services
Healthcare Business Consulting
Healthcare Competitive Intelligence Services
Healthcare Asset Prioritization Services
About DelveInsight
DelveInsight is a leading Business Consultant, and Market Research firm focused exclusively on life sciences. It supports Pharma companies by providing comprehensive end-to-end solutions to improve their performance.
Contact Us
Sandeep Joshi
info@delveinsight.com
+1(919)321-6187
https://www.delveinsight.com/medical-devices